Postoperative Pain Therapy With Hydromorphone TCI-PCA vs. Morphine PCA
- Registration Number
- NCT02483221
- Lead Sponsor
- University of Erlangen-Nürnberg Medical School
- Brief Summary
Treatment of postoperative pain with hydromorphone (a strong analgesic) using patient-controlled analgesia with target-controlled infusion compared to conventional patient-controlled analgesia with morphine after elective cardiac surgery
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
- Written informed consent
- Scheduled for elective cardiac surgery involving thoracotomy and subsequent ICU stay
- Administration of other analgesics or sedatives, if not administered in stable dosages for at least 14 days or if not used for premedication and surgery
- Administration of hydromorphone or morphine in the period between screening and surgery
- Severe hepatic or renal impairment in medical history
- BMI>= 35 ASA>= 4
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description TCI-PCA Hydromorphone - PCA Morphine -
- Primary Outcome Measures
Name Time Method Numerical Rating Score up to 17 hours after extubation Comparison of pain analgetic efficacy between hydromorphone TCI-PCA and conventional morphine PCA during the early postoperative stage
- Secondary Outcome Measures
Name Time Method Respiratory Frequency up to 17 hours after extubation Comparison of opioid induced respiratory depression between hydromorphone TCI-PCA and conventional morphine PCA during the early postoperative stage
Modified Observer's Assessment of Alertness/Sedation Scale up to 17 hours after extubation Comparison of opioid induced sedation level between hydromorphone TCI-PCA and conventional morphine PCA during the early postoperative stage
Postoperative Nausea and Vomiting day of surgery Comparison of opioid associated nausea and vomiting between hydromorphone TCI-PCA and conventional morphine PCA during the early postoperative stage
Trial Locations
- Locations (1)
Department of Anesthesiology, University Hospital Erlangen
🇩🇪Erlangen, Bavaria, Germany